Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Mark Wener and Keith Jerome.
Mark Wener
Connection Strength
0.346
Keith Jerome
  1. Anti-SARS-CoV-2 Antibody Levels Measured by the AdviseDx SARS-CoV-2 Assay Are Concordant with Previously Available Serologic Assays but Are Not Fully Predictive of Sterilizing Immunity. J Clin Microbiol. 2021 08 18; 59(9):e0098921.
    View in: PubMed
    Score: 0.060
  2. Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial. EClinicalMedicine. 2021 Mar; 33:100773.
    View in: PubMed
    Score: 0.058
  3. Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates. J Clin Invest. 2021 02 01; 131(3).
    View in: PubMed
    Score: 0.058
  4. Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial. Ann Intern Med. 2021 03; 174(3):344-352.
    View in: PubMed
    Score: 0.057
  5. SARS-CoV-2 Viral Load on Admission Is Associated With 30-Day Mortality. Open Forum Infect Dis. 2020 Dec; 7(12):ofaa535.
    View in: PubMed
    Score: 0.057
  6. Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho. J Clin Microbiol. 2020 07 23; 58(8).
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.